1. Home
  2. NCSM vs STRO Comparison

NCSM vs STRO Comparison

Compare NCSM & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$39.01

Market Cap

97.3M

Sector

Energy

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$11.52

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
STRO
Founded
2006
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
85.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
NCSM
STRO
Price
$39.01
$11.52
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$18.29
AVG Volume (30 Days)
14.6K
105.4K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
N/A
Revenue
$178,000,000.00
$105,646,000.00
Revenue This Year
$11.25
$63.08
Revenue Next Year
$7.76
N/A
P/E Ratio
$8.82
N/A
Revenue Growth
16.49
N/A
52 Week Low
$23.89
$5.23
52 Week High
$53.69
$21.50

Technical Indicators

Market Signals
Indicator
NCSM
STRO
Relative Strength Index (RSI) 47.78 73.40
Support Level $39.00 $10.15
Resistance Level $40.69 $12.18
Average True Range (ATR) 1.51 0.88
MACD -0.20 -0.20
Stochastic Oscillator 13.36 77.27

Price Performance

Historical Comparison
NCSM
STRO

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: